Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Fresenius Kabi announced today the introduction of Glucagon for Injection in the United States. Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition.
Subscribe to our email newsletter
Fresenius Kabi Glucagon for Injection is indicated for use as a diagnostic aid during radiologic examinations and is available in 10-packs of 1mg vials.
"Glucagon for Injection is the newest addition to our expanding portfolio of specialty injectable products," said John Ducker, president and CEO of Fresenius Kabi USA.
"We are committed to offering customers a broad portfolio and exceptional service, and we’re pleased to now introduce another choice for Glucagon."
Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.
The company’s products and services are used to help care for critically and chronically ill patients. The company’s U.S. headquarters is in Lake Zurich, Illinois. The company’s global headquarters is in Bad Homburg, Germany.